Stephen Maebius and Jennie Zheng Contribute to Article on Next-Gen Bioprinted Products
March 14, 2023
IEEE Pulse
Foley & Lardner LLP Partner Stephen Maebius and Patent Agent Jennie Zheng contributed to an article in IEEE Pulse titled, “ Next Generation Bioprinted Products: Products of Nature or Patentable Innovation ” in Volume 14, Issue 1 of the publication.
The authors describe the process of bioprinting, and its present use cases to generate a diverse range of products like ear and bone and its future potential across further complex matters, including a wide range of human organs. They then discuss the many aspects of bioprinting that are patent eligible, and examine potential strategies that may allow U.S. patents to be granted even on the end products.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."